209106976	209106976	CD	B-NP	O
|	|	NNP	I-NP	O
UGH	UGH	NNP	I-NP	O
|	|	VBD	B-VP	O
00907967	00907967	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6930344	6930344	CD	B-NP	O
|	|	CC	I-NP	O
8/20/2005	8/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/15/2005	7/15/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2005	11/20/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
MACCARINO	MACCARINO	NNP	B-NP	O
,	,	,	O	O
BURL	BURL	NNP	B-NP	O
J	J	NNP	I-NP	O
100-68-32-5	100-68-32-5	CD	I-NP	O
Lum	Lum	NNP	I-NP	O
Van	Van	NNP	I-NP	O
Vallille	Vallille	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
5/23/05	5/23/05	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
TIMBERLAKE	TIMBERLAKE	NNP	B-NP	O
,	,	,	O	O
MONROE	MONROE	NNP	B-NP	O
SHANE	SHANE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
B.CH	B.CH	NNP	B-NP	O
.	.	.	O	O

CODE	CODE	NN	B-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
COLCHICINE	COLCHICINE	NN	I-NP	I-protein
0.6	0.6	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
FOLATE	FOLATE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
LASIX	LASIX	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
ZAROXOLYN	ZAROXOLYN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
METOLAZONE	METOLAZONE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2.5	2.5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
3x/Week	3x/Week	NNP	I-NP	O
M-W-F	M-W-F	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/25	11/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

OXYCODONE	OXYCODONE	RB	B-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q8H	Q8H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/25	11/25	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
PHENOBARBITAL	PHENOBARBITAL	NNP	I-NP	O
180	180	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/25	11/25	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
OXYCONTIN	OXYCONTIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
OXYCODONE	OXYCODONE	NNP	I-NP	I-protein
CONTROLLED	CONTROLLED	NNP	I-NP	I-protein
RELEASE	RELEASE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q12H	Q12H	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
38	38	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
ECASA	ECASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
15	15	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

Food/Drug	Food/Drug	NN	B-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/23/05	5/23/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
SERIOUS	SERIOUS	NNS	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
12.5	12.5	CD	B-NP	O
mg	mg	NN	I-NP	O
five	five	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/23/05	5/23/05	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
SERIOUS	SERIOUS	NNS	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
PHENOBARBITAL	PHENOBARBITAL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
MAGNESIUM	MAGNESIUM	NN	I-NP	O
GLUCONATE	GLUCONATE	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
TLH	TLH	NN	B-NP	O
Potassium	Potassium	NN	I-NP	O
Chloride	Chloride	NN	I-NP	O
Policy	Policy	NN	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	B-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
LISPRO	LISPRO	NNP	I-NP	O
SC	SC	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
AC	AC	NN	B-NP	O
and	and	CC	I-NP	O
QHS	QHS	NN	I-NP	O
as	as	IN	B-PP	O
directed	direct	VBN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Tausch	Tausch	NNP	I-NP	O
4/5	4/5	CD	I-NP	O
3	3	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Witwer	Witwer	NNP	I-NP	O
call	call	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
9/8/05	9/8/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
7	7	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
MEPERIDINE	MEPERIDINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
SILDENAFIL	SILDENAFIL	NNP	B-NP	O
CITRATE	CITRATE	NNP	I-NP	O
,	,	,	O	O
GABAPENTIN	GABAPENTIN	NNP	B-NP	B-protein
,	,	,	O	O
SPIRONOLACTONE	SPIRONOLACTONE	NN	B-NP	O
,	,	,	O	O
NITRATE	NITRATE	NN	B-NP	O
,	,	,	O	O
DIGOXIN	DIGOXIN	NN	B-NP	B-protein
,	,	,	O	O
AMLODIPINE	AMLODIPINE	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
VV	VV	NNP	I-NP	O
pacer	pacer	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Afib	Afib	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CVA	CVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cerebrovascular	cerebrovascular	JJ	I-NP	O
accident	accident	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Peripheral	Peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Obesity	Obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PVD	PVD	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CRI	CRI	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
MMP	MMP	NN	I-NP	O
including	include	VBG	B-PP	O
ischemic	ischemic	JJ	B-NP	O
CMP	CMP	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
A-fib/BiV	A-fib/BiV	NN	B-NP	O
PM	PM	NN	I-NP	O
-	-	HYPH	B-NP	O
multiple	multiple	JJ	I-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
for	for	IN	B-PP	O
CHF	CHF	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
-	-	HYPH	O	O
presents	present	VBZ	B-VP	O
w	w	NN	B-NP	B-protein
1-2	1-2	CD	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
worsening	worsen	VBG	B-VP	O
dyspnea	dyspnea	NN	B-NP	O
.	.	.	O	O

Recently	Recently	RB	B-ADVP	O
restarted	restart	VBN	B-VP	O
on	on	IN	B-PP	O
lisinopril	lisinopril	NN	B-NP	O
-	-	HYPH	O	O
became	become	VBD	B-VP	O
hyperkalemic	hyperkalemic	JJ	B-ADJP	O
-	-	HYPH	B-NP	O
lasix	lasix	NN	I-NP	O
and	and	CC	I-NP	O
zaroxolyn	zaroxolyn	NN	I-NP	O
were	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
fevers	fever	NNS	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
lightheadness	lightheadness	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
AICD	AICD	NNP	I-NP	O
firing	firing	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
as	as	IN	B-PP	O
above	above	JJ	B-NP	O
-	-	HYPH	I-NP	O
ho	ho	NN	I-NP	O
CVA	CVA	NN	I-NP	O
w	w	NN	I-NP	O
word	word	NN	I-NP	O
finding	find	VBG	B-VP	O
difficulties	difficulty	NNS	B-NP	O
-	-	HYPH	B-NP	O
Admit	Admit	NN	I-NP	O
Labs	Lab	NNS	I-NP	O
:	:	:	O	O
Cr	Cr	NN	B-NP	O
1.4	1.4	CD	B-NP	O
K	K	NN	I-NP	O
4.5	4.5	CD	B-NP	O
trop	trop	NN	I-NP	O
neg	neg	NN	I-NP	O
No	No	NN	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
-	-	:	O	O
V	V	NN	B-NP	O
paced	pace	VBD	B-VP	O
,	,	,	O	O
LBBB	LBBB	NNP	B-NP	B-protein
,	,	,	O	O
LAD	LAD	NNP	B-NP	O
VSS	VSS	NNP	I-NP	O
BP	BP	NN	I-NP	O
130/70	130/70	CD	I-NP	O
HR	HR	NN	I-NP	O
80	80	CD	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
word	word	NN	I-NP	O
finding	find	VBG	B-VP	O
difficultues	difficultue	NNS	B-NP	O
-	-	HYPH	O	O
JVP	JVP	NN	B-NP	B-protein
15	15	CD	I-NP	I-protein
+	+	SYM	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
CTA	CTA	NN	I-NP	O
,	,	,	O	O
HRT	HRT	NN	B-NP	O
2/6	2/6	CD	I-NP	O
harsh	harsh	JJ	I-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
apex	apex	NN	B-NP	O
rad	rad	NN	I-NP	O
to	to	TO	B-PP	O
LUSB	LUSB	NN	B-NP	B-protein
+	+	SYM	B-NP	O
s3	s3	NN	I-NP	O
,	,	,	O	O
ext	ext	JJ	B-NP	O
2-3	2-3	NN	I-NP	O
+	+	SYM	B-VP	O
PE	PE	NN	B-NP	B-protein
L	L	NN	I-NP	I-protein
>	>	SYM	B-NP	I-protein
R	R	NN	I-NP	I-protein
-	-	HYPH	O	O
motor/sensory	motor/sensory	JJ	B-NP	O
intact	intact	JJ	I-NP	O
-	-	HYPH	B-VP	O
no	no	DT	B-NP	O
deficits	deficit	NNS	I-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
new	new	JJ	B-NP	O
mass	mass	NN	I-NP	O
in	in	IN	B-PP	O
RUL	RUL	NN	B-NP	B-protein
labs	lab	NNS	I-NP	I-protein
:	:	:	O	O
cr	cr	NN	B-NP	O
1.4	1.4	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
2.3	2.3	CD	I-NP	O
on	on	IN	B-PP	O
9/21	9/21	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-protein
128	128	CD	I-NP	I-protein
CKMB	CKMB	NN	I-NP	I-protein
:	:	:	O	O
7.3	7.3	CD	B-NP	O
trop	trop	NN	I-NP	O
flat	flat	JJ	I-NP	O
Course	Course	NN	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
ED	ED	VBN	B-NP	O
given	give	VBN	I-NP	O
60	60	CD	B-NP	O
IV	IV	CD	I-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	O	O
put	put	VBD	B-VP	O
out	out	RP	B-PRT	O
700cc	700cc	NN	B-NP	O
.	.	.	O	O

all	all	DT	B-NP	O
:	:	:	O	O
multiple	multiple	JJ	B-NP	O
SH	SH	NN	I-NP	O
:	:	:	O	O
smoker	smoker	NN	B-NP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
70	70	CD	B-NP	O
Yo	Yo	NN	I-NP	O
ischemic	ischemic	JJ	I-NP	O
CMP	CMP	NN	I-NP	O
w	w	NN	I-NP	O
decompensated	decompensate	VBD	B-VP	O
CHF	CHF	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
diuretic	diuretic	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
fluid	fluid	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
-	-	HYPH	B-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
weight	weight	NN	I-NP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
114	114	CD	I-NP	O
lbs	lb	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

ACE	ACE	NN	B-NP	O
inh	inh	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	B-protein
55	55	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
w	w	NN	I-NP	I-protein
mod	mod	NN	I-NP	I-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
AS	AS	NN	I-NP	O
.	.	.	O	O

I	I	LS	B-LST	O
:	:	:	O	O
known	know	VBN	B-NP	O
ho	ho	NN	I-NP	O
CAD	CAD	NN	I-NP	O
-	-	HYPH	O	O
ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NNP	B-NP	O
R	R	NNP	I-NP	O
:	:	:	O	O
ho	ho	NN	B-NP	O
A-fib	A-fib	NN	I-NP	O
,	,	,	O	O
V	V	NN	B-NP	O
paced	pace	VBN	B-VP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
-	-	HYPH	O	O
held	hold	VBN	B-VP	O
initially	initially	RB	B-ADVP	O
for	for	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
>	>	SYM	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
then	then	RB	O	O
re-started	re-started	JJ	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
since	since	IN	B-PP	O
2.6	2.6	CD	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

PM	PM	NN	B-NP	O
NEURO	NEURO	NN	I-NP	O
:	:	:	O	O
ho	ho	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
phenobarbitol	phenobarbitol	NN	B-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
diabetes	diabete	NNS	B-NP	O
,	,	,	O	O
hyperkalemia	hyperkalemia	NN	B-NP	O
:	:	:	O	O
Held	Held	JJ	B-NP	O
ACE	ACE	NN	I-NP	O
and	and	CC	O	O
watched	watch	VBD	B-VP	O
lytes	lyte	NNS	B-NP	O
on	on	IN	B-PP	O
IV	IV	CD	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
and	and	CC	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
stable	stable	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
.	.	.	O	O

DNR-not	DNR-not	JJ	B-NP	O
DNI	DNI	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
re-start	re-start	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
this	this	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
follow-up	follow-up	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
do	do	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Needs	Need	VBZ	B-VP	O
outpt	outpt	JJ	B-NP	O
CT	CT	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
RUL	RUL	NN	B-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
outpatient	outpatient	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
STOVER	STOVER	NN	B-NP	O
,	,	,	O	O
FABIAN	FABIAN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TI919	TI919	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/23/05	5/23/05	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

